Advertisement
Home »

Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines.

Sep 25, 2023

ABOUT THE CONTRIBUTORS

  • Madeline Kim

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Yael Renert-Yuval

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States; Pediatric Dermatology Unit, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

    Polina Stepensky

    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

    Ehud Even-Or

    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

    Irina Zaidman

    Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

    Tahel Fachler

    Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

    Michal Neumark

    Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.

    Mariana Zamir

    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.

    Monali NandyMazumdar

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Digpal Gour

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Paola Facheris

    Department of Dermatology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.

    Britta Carroll

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Ying Liu

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Mitchelle L Yu Ekey

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Elizabeth Andrews

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Marguerite Meariman

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Michael Angelov

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Swaroop Bose

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Yeriel D Estrada

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.

    Vered Molho-Pessach

    Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel. Electronic address: rverem@hadassah.org.il.

    Emma Guttman-Yassky

    Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: emma.guttman@mountsinai.org.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement